Balanced news tone
News Sentiment
ANL sentiment intelligence
Adlai Nortye Ltd. American Depositary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+4.0% over one week, -4.4% over four weeks, trend active, and materially above fair value.
Enterprise value to EBITDA forward of Adlai Nortye Ltd. – NASDAQ:ANL
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to EBITDA forward of Adlai Nortye Ltd. – NASDAQ:ANL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:23
- Source
- TradingView
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Adlai Nortye expands scientific advisory board with two oncologists By Investing.com
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 11:31
- Source
- Investing.com Canada
Adlai Nortye Expands Scientific Advisory Board with Appointments of Dr. David S. Hong and Dr. Piro Lito
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 11:13
- Source
- Quiver Quantitative
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 13 Jul 2026 11:00
- Source
- GlobeNewswire
Two cancer drug specialists join Adlai Nortye’s science board
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 11:00
- Source
- Stock Titan
Price to book forward of Adlai Nortye Ltd. – NASDAQ:ANL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 09:20
- Source
- TradingView
Adlai Nortye CEO Lu Yang sells $131 in company stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Investing.com
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's What You Should Know
- Tone
- Positive 76/100
- Event
- Analyst action
- Published
- 20 May 2026 16:00
- Source
- Zacks
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- qz.com
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Adlai Nortye (ANL): 10 Tiny Stocks That Are On Fire Right Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 17:00
- Source
- Insider Monkey
Adlai Nortye: Recapitalized, Refocused, But Still Too Early To Upgrade (NASDAQ:ANL)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 29 Apr 2026 07:00
- Source
- Seeking Alpha
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Adlai Nortye raises $150M in oversubscribed private placement
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Investing.com
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- GlobeNewswire
Adlai Nortye (ANL) Loss Narrows To US$18.3 Million Challenging Bearish Cash Burn Narrative
- Tone
- Negative 18/100
- Event
- Balance sheet
- Published
- 12 Apr 2026 07:00
- Source
- simplywall.st
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 19 Mar 2026 07:00
- Source
- Market source
Adlai Nortye Ltd.'s (NASDAQ:ANL) market cap surged US$65m last week, retail investors who have a lot riding on the company were rewarded
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jan 2026 08:00
- Source
- simplywall.st
Individual investors are Adlai Nortye Ltd.'s (NASDAQ:ANL) biggest owners and were rewarded after market cap rose by US$65m last week
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jan 2026 08:00
- Source
- Market source
Aggressive licensor, cancer-focused Adlai Nortye files for US IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Aug 2023 07:00
- Source
- BioWorld News